Crude incidence rate of any cancer and individual site of cancer among exclusive users of insulin glargine vs. intermediate/long-acting human insulin (HI).
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Crude_incidence_rate_of_any_cancer_and_individual_site_of_cancer_among_exclusive_users_of_insulin_glargine_vs_intermediate_long_acting_human_insulin_HI_/431443
下载链接
链接失效反馈官方服务：
资源简介：
aTotal follow-up person-year for women: 6,558.8 for insulin glargine users and 47,724.6 for HI users.bTotal follow-up person-year for men: 6,458.8 for insulin glargine users and 42,624.4 for HI users.
创建时间：
2015-12-02
